Resveratrol Saffron Supplement for AMD Retinal Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current solutions for age-related macular degeneration (AMD) are limited, and there is a need for effective preventative interventions to reduce the burden of vision loss, as existing dietary supplements do not adequately address the multifactorial causes of AMD, including oxidative stress, photo-oxidative damage, and inflammation.
Innovation Solution
A dietary supplement composition combining resveratrol and saffron, optionally with additional ingredients like lutein, zeaxanthin, omega-3 fatty acids, and antioxidants, which provides synergistic benefits by addressing multiple pathways to protect retinal cells and slow the progression of AMD.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional dietary supplements (AREDS1 formulation) are used to address AMD, then some protective effects are achieved, but the multifactorial causes of AMD including oxidative stress, photo-oxidative damage, and inflammation are not adequately addressed
Solution Approach 1:
The patent combines multiple active ingredients (resveratrol, saffron, lutein, zeaxanthin, omega-3 fatty acids, and antioxidants) into a single dietary supplement formulation. This merging of components allows the supplement to simultaneously address multiple pathways including oxidative stress, photo-oxidative damage, and inflammation, thereby achieving both protective effects and comprehensive coverage of AMD causes.
Solution Approach 2:
The dietary supplement is designed to perform multiple functions: it provides antioxidant protection, reduces inflammation, protects against photo-oxidative damage, and supports retinal health. By incorporating ingredients with diverse biological activities, the supplement achieves multi-functionality that adequately addresses the multifactorial causes of AMD while maintaining reliability in prevention.
2Reliability
If a combination of multiple ingredients is used to address multiple pathways, then comprehensive protection is achieved, but the complexity of the formulation increases
Solution Approach 1:
Multiple ingredients are merged into a single integrated dietary supplement formulation that can be administered as one product. This approach achieves comprehensive protection by combining the benefits of resveratrol, saffron, lutein, zeaxanthin, omega-3 fatty acids, and antioxidants while avoiding the complexity of managing multiple separate supplements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination of resveratrol and saffron, along with other antioxidants, effectively reduces the severity of AMD by inhibiting damaging factors and enhancing protective effects, offering significant benefits in reducing the risk of developing macular degeneration and slowing its progression, while being well-tolerated by living tissue.
Implementation Method 1
The combination of resveratrol and saffron, along with other antioxidants, effectively reduces the severity of AMD by inhibiting damaging factors
Implementation Method 2
The combination of resveratrol and saffron, along with other antioxidants, effectively reduces the severity of AMD by inhibiting damaging factors and enhancing protective effects
Data Source
AI summary
A dietary supplement composition includes a synergistic combination of saffron and resveratrol for providing anti-oxidant and gene modulation effects for preventing, ameliorating and/or reducing a rate of development and progression of age-related macular degeneration (AMD). Optionally, the combination is supplemented with one or more further ingredients: fish oil, Zinc, Copper, vitamin C, vitamin E, lutein, zeaxanthin. The combination is beneficially provided as a composition which is useful for reducing a risk of developing, and/or for reducing a rate of progression of age-related macular degeneration, and/or for preventing age-related sight loss, and other age-related diseases.